Regimens for Drug-Resistant Tuberculosis. Reply
N Engl J Med
.
2023 Jan 12;388(2):190-191.
doi: 10.1056/NEJMc2213970.
Authors
Juliano Timm
1
,
Angela M Crook
2
,
Eugene Sun
3
Affiliations
1
TB Alliance, New York, NY juliano.timm@tballiance.org.
2
University College London, London, United Kingdom.
3
TB Alliance, New York, NY.
PMID:
36630638
DOI:
10.1056/NEJMc2213970
No abstract available
Publication types
Letter
Comment
MeSH terms
Diarylquinolines
Humans
Linezolid
Tuberculosis, Multidrug-Resistant* / drug therapy
Substances
bedaquiline
Linezolid
pretomanid
Diarylquinolines
Grants and funding
MC_UU_00004/04/MRC_/Medical Research Council/United Kingdom
MC_UU_12023/27/MRC_/Medical Research Council/United Kingdom